CRISPR activation screens map the genomic landscape of cancer glycome remodeling
John Daly, Lidia Piatnitca, Mohammed Al‐Seragi, Vignesh Krishnamoorthy, Simon Wisnovsky
This study uses CRISPR activation screens to identify genetic pathways regulating Siglec-binding glycans in cancer, revealing novel targets for immunotherapy.
Cell Genomics · Jan 28, 2026Peer-reviewedGenomics